Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
European Journal of Neurology|February 14, 2023
Immunization status in patients with multiple sclerosis: A cross-sectional, monocenter study in AustriaKlaus Berek, Philipp Deisl, Maximilian Bichler, et al.Wiener Klinische Wochenschrift|December 14, 2020
6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohortFlorian Deisenhammer, Wegene Borena, Angelika Bauer, et al.Plos One|June 12, 2020
Influence of physical activity on serum vitamin D levels in people with multiple sclerosisAngelika Bauer, Ivan Lechner, Michael Auer, et al.Multiple Sclerosis and Related Disorders|October 23, 2017
Validation of an environmentally-friendly and affordable cardboard 9-hole peg testNicolas Dubuisson, Angelika Bauer, Mark Buckley, et al.CNS Drugs|September 29, 2022
Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and Natalizumab Serum Concentration as Potential Biomarkers for Pharmacodynamics and Treatment Response of Patients with Multiple Sclerosis Receiving NatalizumabMichael Auer, Angelika Bauer, Antonia Oftring, et al.Frontiers in Immunology|November 5, 2021
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Varicella Zoster Virus Infection - Frequency of an AssociationFranziska Di Pauli, Paul Morschewsky, Klaus Berek, et al.Frontiers in Immunology|December 1, 2022
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorderAngelika Bauer, Dagmar Rudzki, Klaus Berek, et al.Frontiers in Neurology|August 12, 2025
High erythropoietin levels are associated with low neurofilament light levels in simulated high altitude: a further hint for neuroprotection by erythropoietinKlaus Berek, Anna Berek, Angelika Bauer, et al.Antimicrobial Agents and Chemotherapy|June 10, 2026
Why intrinsic reduced susceptibility in rare fungal pathogens should be differentiated from intrinsic resistance: an ISHAM conceptual framework and narrative reviewCornelia Lass-Flörl, Stephan Steixner, Angelika Bauer, et al.Brain Communications|April 5, 2024
Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses?Kathrin Schanda, Sara Mariotto, Dagmar Rudzki, et al.Pageof 3